JP2021023231A5 - - Google Patents

Download PDF

Info

Publication number
JP2021023231A5
JP2021023231A5 JP2019145173A JP2019145173A JP2021023231A5 JP 2021023231 A5 JP2021023231 A5 JP 2021023231A5 JP 2019145173 A JP2019145173 A JP 2019145173A JP 2019145173 A JP2019145173 A JP 2019145173A JP 2021023231 A5 JP2021023231 A5 JP 2021023231A5
Authority
JP
Japan
Prior art keywords
bifidobacteria
cytokine production
inflammatory cytokine
inducing activity
nite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019145173A
Other languages
English (en)
Japanese (ja)
Other versions
JP7013419B2 (ja
JP2021023231A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2019145173A external-priority patent/JP7013419B2/ja
Priority to JP2019145173A priority Critical patent/JP7013419B2/ja
Priority to CN202080022843.5A priority patent/CN113597467A/zh
Priority to EP20850115.5A priority patent/EP4011216B1/en
Priority to KR1020217036918A priority patent/KR20220038588A/ko
Priority to PCT/JP2020/029299 priority patent/WO2021024915A1/ja
Priority to TW109126409A priority patent/TW202115104A/zh
Publication of JP2021023231A publication Critical patent/JP2021023231A/ja
Publication of JP2021023231A5 publication Critical patent/JP2021023231A5/ja
Publication of JP7013419B2 publication Critical patent/JP7013419B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019145173A 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 Active JP7013419B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2019145173A JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
PCT/JP2020/029299 WO2021024915A1 (ja) 2019-08-07 2020-07-30 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
EP20850115.5A EP4011216B1 (en) 2019-08-07 2020-07-30 Bifidobacteria having low activity of inducing inflammatory cytokine production but high activity of inducing anti-inflammatory cytokine production
KR1020217036918A KR20220038588A (ko) 2019-08-07 2020-07-30 염증성 사이토카인의 산생 유도 활성은 낮지만 항염증성 사이토카인의 산생 유도 활성이 높은 비피더스균
CN202080022843.5A CN113597467A (zh) 2019-08-07 2020-07-30 具有诱导炎症性细胞因子产生的低活性但诱导抗炎性细胞因子产生的高活性的双歧杆菌
TW109126409A TW202115104A (zh) 2019-08-07 2020-08-05 發炎性細胞介素之產生誘導活性低但抗發炎性細胞介素之產生誘導活性高的雙叉乳酸桿菌

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019145173A JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌

Publications (3)

Publication Number Publication Date
JP2021023231A JP2021023231A (ja) 2021-02-22
JP2021023231A5 true JP2021023231A5 (cg-RX-API-DMAC10.html) 2021-11-11
JP7013419B2 JP7013419B2 (ja) 2022-02-15

Family

ID=74504115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019145173A Active JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌

Country Status (6)

Country Link
EP (1) EP4011216B1 (cg-RX-API-DMAC10.html)
JP (1) JP7013419B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220038588A (cg-RX-API-DMAC10.html)
CN (1) CN113597467A (cg-RX-API-DMAC10.html)
TW (1) TW202115104A (cg-RX-API-DMAC10.html)
WO (1) WO2021024915A1 (cg-RX-API-DMAC10.html)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
JP4589618B2 (ja) 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン10産生促進剤
AU2009315298A1 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
ES2778836T3 (es) * 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
RU2557310C2 (ru) * 2009-11-11 2015-07-20 Алиментари Хелс Лимитед ШТАММ Bifidobacterium longum, ПРИГОДНЫЙ ДЛЯ ПРИМЕНЕНИЯ В ИММУНОМОДУЛЯЦИИ, ИНДУКЦИИ ПРОДУКЦИИ ЦИТОКИНОВ, ЛЕЧЕНИИ АУТОИММУННОГО ЗАБОЛЕВАНИЯ, КОНТРОЛЕ ОТНОШЕНИЯ IL - 10:IL - 12, И ЕГО ИСПОЛЬЗОВАНИЕ
WO2012014971A1 (ja) * 2010-07-30 2012-02-02 株式会社明治 メタボリックシンドローム改善効果を有する乳酸菌
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP3194567B1 (en) * 2014-08-29 2019-10-30 Chr. Hansen A/S Probiotic bifidobacterium adolescentis strains

Similar Documents

Publication Publication Date Title
JP2023164986A5 (cg-RX-API-DMAC10.html)
JP2026012786A5 (cg-RX-API-DMAC10.html)
JP2023113681A5 (cg-RX-API-DMAC10.html)
JP2023134519A5 (cg-RX-API-DMAC10.html)
RU2019110063A (ru) ПРОБИОТИЧЕСКИЕ ШТАММЫ БАКТЕРИЙ, ОТНОСЯЩИХСЯ К РОДУ Bifidobacterium, И ПРОБИОТИЧЕСКИЕ ЭКСТРАКТЫ ЭТИХ КЛЕТОК (PCE), ОБЛАДАЮЩИЕ ИММУНОСТИМУЛИРУЮЩИМИ СВОЙСТВАМИ
JP2023153863A5 (cg-RX-API-DMAC10.html)
JP2004535435A5 (cg-RX-API-DMAC10.html)
WO2016103269A8 (en) Populations of neural progenitor cells and methods of producing and using same
JP2009062604A5 (cg-RX-API-DMAC10.html)
WO2010055499A3 (en) Bifidobacterium longum
JP2013505359A5 (cg-RX-API-DMAC10.html)
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
JP2023139025A5 (cg-RX-API-DMAC10.html)
JP2019518874A5 (cg-RX-API-DMAC10.html)
JP2024088648A5 (cg-RX-API-DMAC10.html)
JP2012105193A5 (cg-RX-API-DMAC10.html)
JP2025163046A5 (cg-RX-API-DMAC10.html)
JP2025124655A5 (cg-RX-API-DMAC10.html)
JP2025041678A5 (cg-RX-API-DMAC10.html)
JP2024160274A5 (cg-RX-API-DMAC10.html)
WO2023137381A3 (en) Bifidobacterium infantis formulations
JP2016031825A5 (cg-RX-API-DMAC10.html)
JP2011093128A5 (cg-RX-API-DMAC10.html)
JP2017528146A5 (cg-RX-API-DMAC10.html)
JP2020020500A5 (cg-RX-API-DMAC10.html)